BioSpace News Archive

Genetic testing can identify causes of rare, progressive eye disorders

BMO today announced a full suite of banking and wealth management services designed specifically to support healthcare professionals – from when they are starting out in postgraduate school, to mid-career, to when they retire.

CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, successfully enrolled the 200th patient in the Agili-C™ IDE pivotal clinical study.

CredSimple, the leading cloud-based healthcare credential verification organization, today announced the closing of a $14 million Series B financing

Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its Simcyp® physiologically-based pharmacokinetic (PBPK) modeling and simulation technology was used to demonstrate bioequivalence (BE) for the US Food and Drug Administration (FDA) approval of a complex generic drug on the agency’s abbreviated new drug application (ANDA) pathway.

Horizon Therapeutics plc (Nasdaq: HZNP) is elevating the dialogue on gout within the medical and scientific community during the Annual European Congress of Rheumatology (EULAR 2019) with a series of data presentations on gout and its systemic implications

Latest funding led by Agilent Technologies with participation from Cota Capital, 5AM Ventures, and Roche Venture Fund

Data Presentations Highlight Continued Advances in Research for Treating Blood Cancers

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present on June 18, 2019 at Raymond James’ Life Sciences and MedTech Conference in New York City. Arthur Przybyl, President and CEO and Stephen Carey, Vice President and CFO, will present at 8:00 AM ET on Tuesday, June 18, 2019.

Details of selected oral and poster presentations by Blue Earth Diagnostics and its collaborators are listed below.